Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Retinal Diseases

rosiglitazone has been researched along with Retinal Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bourne, PC; Dou, X; Duerfeldt, AS; Ma, JX; Nath, D; Nurmemmedov, E; Shin, H1
Kendall, C; Wooltorton, E1
Sivagnanam, G1

Other Studies

3 other study(ies) available for rosiglitazone and Retinal Diseases

ArticleYear
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARĪ± Agonists as Leads for Retinal Disorders.
    Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6

    Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin

2020
Rosiglitazone (Avandia) and macular edema.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Feb-28, Volume: 174, Issue:5

    Topics: Adverse Drug Reaction Reporting Systems; Canada; Edema; Humans; Retinal Diseases; Rosiglitazone; Thiazolidinediones

2006
Rosiglitazone and macular edema.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Aug-01, Volume: 175, Issue:3

    Topics: Contraindications; Diabetes Complications; Edema; Humans; Retinal Diseases; Risk Factors; Rosiglitazone; Thiazolidinediones

2006